Founded in 2015, Fontus has been the early Chinese biotech equity investor on assets behind multiple multi-billion-dollar new Co. and licensing deals. We institutionalize this position into a disciplined deal-driven investment strategy that leverages a competitive sourcing model and diverse exit pathways. Fontus is being managed by Prof. Xinliang Shen and Duan Xiang (Danny) with decades of biotech investment experience. Both possess strong historical track records demonstrating capabilities to validate innovation at pre-clinical stage and empower portfolio growth.
| Website | http://en.fontus.com.hk/ |
| Employees | 10 (2 on RocketReach) |
| Founded | 2015 |
| Industry | Venture Capital and Private Equity Principals |
Looking for a particular Fontus Capital employee's phone or email?
Ming G. is the Partner of Fontus Capital.
2 people are employed at Fontus Capital.